Becoming a public benefit corporation aligns United Therapeutics' corporate structure with our foundational DNA and gives us a strong platform to advance our objectives of developing novel pharmaceutical therapies and finding a cure for end-stage organ diseases by creating an unlimited supply of transplantable organs.
Dr. Martine Rothblatt Founder, Chairperson, and Chief Executive Officer

United Therapeutics is a
Public Benefit Corporation

Since our launch, we have operated with a patient-driven mission, strong values, and long-term vision. In 2021, following overwhelming approval by our shareholders, we converted our company from a traditional Delaware corporation into a Delaware public benefit corporation (PBC). This aligns our legal form with our longstanding commitment to serve our patients and we believe, among other things, enhances our ability to create superior and sustainable value for our shareholders. We are the first publicly traded biotechnology company organized as a PBC.

Learn More

Our Purpose

Our purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies and technologies that expand the availability of transplantable organs.

Our Key Stakeholders

Our Patients

PBC Goals for Our Patients

Address unserved needs

No patient left behind

Priority Linked ESG Issues*
  • Patient Safety, Product Quality, and Supply Chain Management
  • Innovation (Research, Development, and Clinical Trials)
  • Healthcare Provider and Patient Awareness and Education
  • Access to Medicine

Our People

PBC Goals for Our People

Be a destination employer

Priority Linked ESG Issues*
  • Diversity, Equity, and Inclusion (DEI)
  • Workplace Safety
  • Employee Attraction, Retention, and Development


PBC Goals for Humankind

Operate sustainably

Priority Linked ESG Issues*
  • Environmental Footprint - including climate related issues
ESG: Environmental, Social, and Governance

Key Enablers Responsible Business Practices

Data Privacy and Security
Compliance, Culture, and Ethics
Enterprise Risk Management and Organizational Resilience

Read more about our PBC goals and performance in our 2023 Report

Cover of the United Therapeutics 2023 Corporate Responsibility and Public Benefit Corporation Report 2023 Corporate Responsibility and Public Benefit Report